STOCKHOLM—The first specialist in pediatric oncology ever to hold office as President of the American Society of Clinical Oncology, Dr Michael Link — Professor of Pediatrics at Stanford University School of Medicine — explains to Peter Goodwin how techniques for treating childhood cancers can be used as models for treating adult malignancy, during the 2011 European Multidisciplinary Cancer Congress held in Stockholm where he chaired a session on “Quality of Delivered Cancer Care”.
You may also like...
Acute promyelocytic leukaemia: arsenic better than chemotherapy to combine with retinoic acid? 18 Dec, 2012 Gene Assay Predicts Which Patients Need Radiation After Prostatectomy 18 Apr, 2017 Venetoclax Pro-Apoptotic Therapy Benefits Older Patients with Acute Myeloid Leukemia 19 Jan, 2018 Oncology Times Broadcast News with the Audio Journal of Oncology – February 2009 9 Feb, 2009
- Previous story Indolent Lymphoma Standard Therapy Needs To Change: Bendamustine-Rituximab: Better Than CHOP-Rituximab
- Next story ASCO 2012 ANNUAL MEETING: Resolving Long Debate, Study Finds Intermittent Hormonal Therapy Less Effective than Continuous Therapy in Certain Men With Advanced Prostate Cancer
- COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014